Nymox Pharma (NYMX) puts active after reporting trial data
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Nymox Pharma (NASDAQ: NYMX) October 2.5 and November 1 puts are active on total put volume of 6,700 contracts (1,560 calls) after reporting new study results from Phase 3 trials for fexopotide. October put option implied volatility is at 245, November is at 250; compared to its 52-week range of 89 to 225.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CBOE (CBOE) Announces New SPX Options Implied Volatility-Based Index: SMILE
- Stocks with Implied Volatility Movement
- General Dynamics (GD) volatility flat on call put ratio of 4 calls to 1 put into Q3
Create E-mail Alert Related CategoriesOptions, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!